Women's Health Innovation Summit, Europe 2022

Women's Health Innovation Summit

Showcasing innovation, fuelling investment, and driving partnerships across Europe and Israel to improve the outcomes, access, and quality of healthcare for women.

Register your Interest
Basel, Switzerland
26-27 April, 2022

Register to see a FREE webinar on 'Advancing menstrual health equity through the power of data and storytelling!

WHI 2022 STEERING COMMITTEE


WHY ATTEND?

Building on the success of the Women’s Health Innovation Summit USA, we are delighted to announce we are coming to Europe to continue the acceleration of innovation and investment in women’s health and Femtech solutions!

Globally, the European women’s health market is one of the fastest growing, with new technologies, therapeutics, devices, platforms and approaches being developed to improve women’s’ access and quality of care.

Our summit will bring together the leaders & innovators from Europe and Israel, from big pharmaceutical and medical device companies, to start-ups, Femtech, VC’s and incubator funds, to drive successful partnerships, showcase leading disruptive solutions, and to fuel the growth of these businesses and the women’s health sector.

Join the leading industry network in women’s health; our 2-day summit is guaranteed to bring value to your business strategy, connections, and growth.

Women's Health Series Past Attendees

FREE TO ATTEND WEBINAR

2022 Partners

Platinum Partner

Gold Partners

AUDIENCE BREAKDOWN

5%
Non-profits/ Advocacy Groups
20%
Investor/Funding Groups
5%
Payors/ Providers/ Employers
35%
Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs
40%
Start Ups/ Femtech/ Entrepreneurs/ Innovation
5%
Service Providers

Non-profits/ Advocacy Groups

Investor/Funding Groups

Payors/ Providers/ Employers

Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs

Start Ups/ Femtech/ Entrepreneurs/ Innovation

Service Providers

Previous Series Speakers

 

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures

Alice Zheng, MD, MBA, MPH

Principal
Rhia Ventures
 

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research

Kathryn G. Schubert, MPP

President and CEO
Society of Women’s Heath Research
 

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson is a nationally recognized innovative leader and change agent for the health of women and their families. As the former Associate Commissioner for Women’s Health at the Food and Drug Administration, for a decade, she progressed and managed cutting-edge policy, research and educational outreach initiatives.

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson

Innovative Leader & Change Agent, Former Associate Commissioner for Women’s Health for FDA
Food and Drug Administration

Marsha B. Henderson is a nationally recognized innovative leader and change agent for the health of women and their families. As the former Associate Commissioner for Women’s Health at the Food and Drug Administration, for a decade, she progressed and managed cutting-edge policy, research and educational outreach initiatives. The Office of Women’s Health advanced its scientific efforts, under her direction, to produce more than 350 research papers and journal articles to facilitate FDA’s regulatory decision-making and promote a better understanding of sex differences and health conditions unique to women. Her tenure produced the first FDA Women’s’ Health Research Roadmap, outlining seven priority areas for new or enhanced research including biomarkers, nanotechnology, cardiovascular disease, and postmarket surveillance as well as a framework to assess its impact. Her colleagues applaud her ability to set a vision and guide the concept to reality. One FDA Commissioner stated, “She is elegant…not just in style but in character, confidence and compassion.”

 

Ms. Henderson’s expertise in the development of public-private partnerships and culturally appropriate consumer engagement strategies led to the Women’s Health Take Time To Care Program, which has reached over 120 million people with FDA consumer information in 18 languages, and received awards from more than 96 national organizations. Her easy to read, science-based materials have been chronicled in Dear Abby, Parade Magazine, Hints from Heloise, and the IRS, as well as sponsored by external groups including the National Association of Chain Drug Stores, American Diabetes Association, Ford Motor Company, American Medical Association, and even Las Vegas casinos. Her novel efforts supported a one-stop Pregnancy Exposure Registries website to gather information about how prescription drugs or vaccines affect a pregnant woman and her fetus. In addition, she recently instructed her staff to expand the Science of Sex and Gender on-line accredited courses with the NIH/Office of Research on Women’s Health and to conduct FDA’s first “Scientific Conference: Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender” to address this national epidemic.

 

She is the recipient of numerous awards including the Dr. Estelle Ramey Award for Women’s Health Leadership from Society for Women’s Health Research; “HerMANA” Award for innovative outreach to Hispanic women, and Pinnacle Award for exceptional leadership in medication use for patients and caregivers.  The first non-pharmacist to receive the prestigious Jacob Miller Award from the American Pharmacists Association Foundation, she was also one of five Samuel J. Heyman Service to America Medal (Sammies) finalists from throughout the U.S. federal government. And as Chair of the national board of the YWCA USA, she led the U.S. delegation at the YWCA World Council quadrennial meeting in Bangkok, Thailand to focus on women’s issues.

Prior to her FDA career, Ms. Henderson served as the Director of Evaluation for the Interagency Council on the Homeless; Director of Placement for the National Health Service Corps; Chief of Analysis and Information for the Bureau of Maternal and Child Health; and Senior Advisor to the Director of the Women's Bureau at the U.S. Department of Labor.  Ms. Henderson earned a master’s degree from Rutgers University in health and hospital planning.  She is married to Wade Henderson, an internationally renowned civil and human rights lawyer.

 

Dr. Sandy Milligan

Head of R&D
Organon

Dr. Sandy Milligan

Head of R&D
Organon

Dr. Sandy Milligan

Head of R&D
Organon
 

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen
 

Dr. Nieca Goldberg

Medical Director
NYU Women’s Heart Program

Dr. Nieca Goldberg

Medical Director
NYU Women’s Heart Program

Dr. Nieca Goldberg

Medical Director
NYU Women’s Heart Program
 

Tracy Warren

Managing Partner
Astarte Ventures

Tracy Warren

Managing Partner
Astarte Ventures

Tracy Warren

Managing Partner
Astarte Ventures
 

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia

Erica Kantor

Medical Sector Manager
Sagentia
 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)

Jamie White

Health Science Strategy and Relations Lead in the Office of Research on Women’s Health (ORWH)
National Institutes of Health (NIH)
 

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON

Deirdre Albertson

Vice President, Project Management, Cardiovascular, Metabolic and Women’s Health
ICON
 

Lauren Demosthenes

Senior Medical Director
Babyscripts

Lauren Demosthenes

Senior Medical Director
Babyscripts

Lauren Demosthenes

Senior Medical Director
Babyscripts
 

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health

Georgie Kovacs

Founder & CEO
Fempower Health
 

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant

Juan Camilo Arjona Ferreira

, MD Chief Medical Officer
Myovant
 

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health

Missy Lavender

CEO
Renalis Health
 

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

 

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan
 

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife

Eric Dy

Founder and CEO
Bloomlife
 

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie

Farida Peters-Abbadi

President & Chief Commercial Officer
Mirvie
 

Omar Dawood

Chief Medical Officer
Calm

Omar Dawood

Chief Medical Officer
Calm

Omar Dawood

Chief Medical Officer
Calm
 

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness

Liz Klinger

CEO
Lioness
 

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth

Rachel Braun Scherl

Managing Partner, Co-Founder, & Chief Vagipreneur ®
SPARK Solutions for Growth
 

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group
 

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG

Nathanial DeNicola

Head Telehealth Committee
ACOG
 

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK

Tania Small

MD, Vice President, Global Medical Affairs Oncology Head
GSK
 

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD

Ally Crays

Youth Advisory Council Chair
PERIOD
 

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares

Rich Jones

EVP & Executive Director
Heritage Cares
 

Michela Bedard

Executive Director
PERIOD

Michela Bedard

Executive Director
PERIOD

Michela Bedard

Executive Director
PERIOD
 

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England

Maggie Perracchio

RN BSN Director Population Health Clinical Program
Health New England
 

Nicole Leeds

Head of Marketing Strategy
Clue

Nicole Leeds

Head of Marketing Strategy
Clue

Nicole Leeds

Head of Marketing Strategy
Clue
 

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health

Jannine Versi

COO & Co-Founder
Elektra Health
 

Allison Conti

Founder & CEO
Watkins-Conti Products

Allison Conti

Founder & CEO
Watkins-Conti Products

Allison Conti

Founder & CEO
Watkins-Conti Products
 

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Kelle Moley, MD

Deputy Director of Reproductive Health Technologies Global Health, Discovery and Translational Sciences
Bill & Melinda Gates Foundation

Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation.  Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.

 

Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.

 

Dr Dan Martin

Scientific and Medical Director
Endometriosis Foundation of America

Dr. Dan Martin is the Scientific and Medical Director of the Endometriosis Foundation of America (www.EndoFound.org). He has studied endometriosis since 1970 with endometriosis publications beginning in 1983.

Dr Dan Martin

Scientific and Medical Director
Endometriosis Foundation of America

Dr Dan Martin

Scientific and Medical Director
Endometriosis Foundation of America

Dr. Dan Martin is the Scientific and Medical Director of the Endometriosis Foundation of America (www.EndoFound.org). He has studied endometriosis since 1970 with endometriosis publications beginning in 1983.

He is a community member of the Virginia Commonwealth University Institutional Review Board, Professor Emeritus of the University of Tennessee Health Science Center, and a life fellow of the American College of Obstetricians and Gynecologists. Dr. Martin is on the editorial boards of three medical journals. He has been Divisional Director of Reproductive Endocrinology and Divisional Director of Minimally Invasive Surgery at the University of Tennessee Health Science Center and Divisional Director of Medical Education at The Johns Hopkins Medical Institutes. He is a Past President of the American Association of Gynecologic Laparoscopists and the Gynecologic Laser Society.

 

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy Perez, PhD

Senior Partner
McKinsey & Company

Lucy Perez, PhD

Senior Partner
McKinsey & Company
 

Tanika Gray Valbrun

Founder
The White Dress Project

Tanika Gray Valbrun

Founder
The White Dress Project

Tanika Gray Valbrun

Founder
The White Dress Project
 

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner

Chief Medical Officer
Obseva

Elizabeth Garner

Chief Medical Officer
Obseva
 

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

 

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson

Founder and CEO
DARÉ Bioscience

Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

 

Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women.  Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.  

 

Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.  

 

Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International. 

Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre.  She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum. 

 

Jennifer Stearns

Managing Director
Accenture, Global Lead “On Our Terms”

Jennifer Stearns

Managing Director
Accenture, Global Lead “On Our Terms”

Jennifer Stearns

Managing Director
Accenture, Global Lead “On Our Terms”
 

Tina Ripperger

Managing Director
Accenture; Global Head of Life Sciences, WhatIf

Tina Ripperger

Managing Director
Accenture; Global Head of Life Sciences, WhatIf

Tina Ripperger

Managing Director
Accenture; Global Head of Life Sciences, WhatIf
 

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures
 

Jessica Federer

Former- CDO at Bayer & Venture Partner
Boston Millennia Partners

Jessica Federer

Former- CDO at Bayer & Venture Partner
Boston Millennia Partners

Jessica Federer

Former- CDO at Bayer & Venture Partner
Boston Millennia Partners
 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant

Kalahn Taylor-Clark, PhD MPH

Vice President, Strategic Partnerships and Innovation
Myovant
 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Linda Dunbar

Diversity Specialist
Diversity Decoder

Linda Dunbar

Diversity Specialist
Diversity Decoder

Linda Dunbar

Diversity Specialist
Diversity Decoder
 

Barb Collura

President/CEO
RESOLVE

Barb Collura

President/CEO
RESOLVE

Barb Collura

President/CEO
RESOLVE
 

Delphine O'Rourke

Partner
Goodwin Law

Delphine O'Rourke

Partner
Goodwin Law

Delphine O'Rourke

Partner
Goodwin Law
 

Valerie Palmieri

CEO
Aspira Women's Health

Valerie Palmieri

CEO
Aspira Women's Health

Valerie Palmieri

CEO
Aspira Women's Health
 

LESLEY NORTHROP, PH.D., DABMGG, FACMG

Chief Scientific Officer
Aspira Women's Health

LESLEY NORTHROP, PH.D., DABMGG, FACMG

Chief Scientific Officer
Aspira Women's Health

LESLEY NORTHROP, PH.D., DABMGG, FACMG

Chief Scientific Officer
Aspira Women's Health
 

Brittany Barreto

Co-Founder
General Partner, Coyote Ventures

Brittany Barreto

Co-Founder
General Partner, Coyote Ventures

Brittany Barreto

Co-Founder
General Partner, Coyote Ventures
 

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association

Sasha Ottey, MHA, MT, (ASCP)

Founder and Executive Director
PCOS Challenge: The National Polycystic Ovary Syndrome Association
 

Chris Jackson

CEO & Founder
Cicero Diagnostics

Chris Jackson

CEO & Founder
Cicero Diagnostics

Chris Jackson

CEO & Founder
Cicero Diagnostics
 

Jessica Hatheway

Clinical Operations
Health Decisions

Jessica Hatheway

Clinical Operations
Health Decisions

Jessica Hatheway

Clinical Operations
Health Decisions
 

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy

Mylene Yao

Co-Founder & CEO
Univfy
 

Charmain F. Jackman, PhD

Founder & CEO
InnoPsych, Inc.

Charmain F. Jackman, PhD

Founder & CEO
InnoPsych, Inc.

Charmain F. Jackman, PhD

Founder & CEO
InnoPsych, Inc.
 

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group
 

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic

Dr. Neel Shah

Chief Medical Officer
Maven Clinic
 

Stephen Palmer, PhD

Chief Scientific Officer
Celmatix

Stephen Palmer, PhD

Chief Scientific Officer
Celmatix

Stephen Palmer, PhD

Chief Scientific Officer
Celmatix
 

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer

Cheryl Kerr

Senior Director Strategy & Portfolio Management Women’s Health
Bayer
 

Primavera Spagnolo, MD, PhD

Scientific Director, Connors Center for Women’s Health and Gender Biology
Brigham and Women’s Hospital

Primavera Spagnolo, MD, PhD

Scientific Director, Connors Center for Women’s Health and Gender Biology
Brigham and Women’s Hospital

Primavera Spagnolo, MD, PhD

Scientific Director, Connors Center for Women’s Health and Gender Biology
Brigham and Women’s Hospital

REGISTER YOUR INTEREST

The conference agenda will be launched soon. Register your interest and be the first to receive it.

Register your Interest

Become a Partner

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.